4//SEC Filing
Atkinson Edward Morrow III 4
Accession 0000875320-24-000101
CIK 0000875320other
Filed
Feb 26, 7:00 PM ET
Accepted
Feb 27, 4:44 PM ET
Size
6.1 KB
Accession
0000875320-24-000101
Insider Transaction Report
Form 4
Atkinson Edward Morrow III
EVP, Chief Technical Ops. Off.
Transactions
- Tax Payment
Common Stock
2024-02-23$431.79/sh−1,654$714,181→ 16,855 total - Sale
Common Stock
2024-02-26$425.70/sh−883$375,893→ 15,972 total
Footnotes (1)
- [F1]Transaction made pursuant to Mr. Atkinson's company approved trading plan under Rule 10b5-1, which was entered into on 8/22/2023.
Documents
Issuer
VERTEX PHARMACEUTICALS INC / MA
CIK 0000875320
Entity typeother
Related Parties
1- filerCIK 0001914164
Filing Metadata
- Form type
- 4
- Filed
- Feb 26, 7:00 PM ET
- Accepted
- Feb 27, 4:44 PM ET
- Size
- 6.1 KB